GOSSAMER BIO, INC. Employee Count
The employee counts GOSSAMER BIO, INC. states in its annual reports on SEC EDGAR, each as filed.
- 2025-12-31: Employees (as filed) 161; Filing 2026-03-17; Lease expense per employee $9,838.51.
- 2024-12-31: Employees (as filed) 144; Filing 2025-03-13; Lease expense per employee $26,069.44.
- 2023-12-31: Employees (as filed) 135; Filing 2024-03-05; Lease expense per employee $23,451.85.
- 2022-12-31: Employees (as filed) 178; Filing 2023-03-17; Lease expense per employee $17,651.69.
- Available history
- 2018-12-31 to 2025-12-31
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2025-12-31 | 161 full-time | 2026-03-17 | $9,838.51 total lease cost |
| 2024-12-31 | 144 full-time | 2025-03-13 | $26,069.44 total lease cost |
| 2023-12-31 | 135 full-time | 2024-03-05 | $23,451.85 total lease cost |
| 2022-12-31 | 178 full-time | 2023-03-17 | $17,651.69 total lease cost |
| 2021-12-31 | 185 full-time | 2022-03-03 | $22,064.86 total lease cost |
| 2020-12-31 | 195 full-time | 2021-02-26 | $18,938.46 total lease cost |
| 2019-12-31 | 171 full-time | 2020-03-24 | $18,385.96 total lease cost |
| 2018-12-31 | 118 full-time | 2019-03-22 | $12,711.86 rent expense, net |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 |